Medicine & Life Sciences
Amyloid
100%
Positron-Emission Tomography
82%
Alzheimer Disease
73%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
53%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
53%
Fluorodeoxyglucose F18
38%
Biomarkers
29%
Cognitive Dysfunction
27%
Atrophy
25%
Apraxias
24%
Aphasia
22%
Brain
22%
Neuroimaging
22%
Primary Progressive Aphasia
21%
Dementia
19%
White Matter
18%
Pathology
16%
Progressive Supranuclear Palsy
15%
Choline
11%
Temporal Lobe
11%
Cognition
11%
Head and Neck Neoplasms
10%
Gray Matter
9%
Magnetic Resonance Imaging
9%
Prostatic Neoplasms
9%
Single-Photon Emission-Computed Tomography
9%
Neoplasms
9%
Apolipoprotein E4
9%
Amyloidosis
8%
Population
8%
Tauopathies
8%
Recurrence
8%
Phenotype
7%
Elderly
7%
Entorhinal Cortex
6%
Radiotherapy
6%
Frontotemporal Dementia
6%
Autopsy
6%
Glucose
6%
Memory
6%
Parietal Lobe
6%
Frontotemporal Lobar Degeneration
6%
Language
6%
Amyloid Plaques
6%
Tomography
6%
Neck
5%
Cognitive Aging
5%
National Institute on Aging (U.S.)
5%